Pfizer Inc. buy Guggenheim
Start price
10.02.25
/
50%
€25.02
Target price
10.02.26
€31.98
Performance (%)
-13.73%
Price
13.01.26
€21.59
Summary
This prediction is currently active. The prediction for Pfizer Inc. disappoints with a performance of -13.73%. This prediction currently runs until 10.02.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | -0.827% | -0.827% |
| iShares Core DAX® | 1.644% | 4.865% |
| iShares Nasdaq 100 | 0.747% | 2.923% |
| iShares Nikkei 225® | 2.442% | 6.212% |
| iShares S&P 500 | 0.618% | 2.843% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $33.00 price target on the stock.
Ratings data for PFE provided by MarketBeat